BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 25116331)

  • 21. Monosomal karyotype is an independent predictor of survival in patients with higher-risk myelodysplastic syndrome.
    Xing R; Li C; Gale RP; Zhang Y; Xu Z; Qin T; Li B; Fang L; Zhang H; Pan L; Hu N; Qu S; Xiao Z
    Am J Hematol; 2014 Oct; 89(10):E163-8. PubMed ID: 25044281
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Monosomal karyotype in myelodysplastic syndromes, with or without monosomy 7 or 5, is prognostically worse than an otherwise complex karyotype.
    Patnaik MM; Hanson CA; Hodnefield JM; Knudson R; Van Dyke DL; Tefferi A
    Leukemia; 2011 Feb; 25(2):266-70. PubMed ID: 21072042
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monosomal karyotype provides better prognostic prediction after allogeneic stem cell transplantation in patients with acute myelogenous leukemia.
    Oran B; Dolan M; Cao Q; Brunstein C; Warlick E; Weisdorf D
    Biol Blood Marrow Transplant; 2011 Mar; 17(3):356-64. PubMed ID: 20553926
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Monosomal karyotype in acute myeloid leukemia: a better indicator of poor prognosis than a complex karyotype.
    Breems DA; Van Putten WL; De Greef GE; Van Zelderen-Bhola SL; Gerssen-Schoorl KB; Mellink CH; Nieuwint A; Jotterand M; Hagemeijer A; Beverloo HB; Löwenberg B
    J Clin Oncol; 2008 Oct; 26(29):4791-7. PubMed ID: 18695255
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Monosomal karyotype predicts poor survival after allogeneic stem cell transplantation in chromosome 7 abnormal myelodysplastic syndrome and secondary acute myeloid leukemia.
    van Gelder M; de Wreede LC; Schetelig J; van Biezen A; Volin L; Maertens J; Robin M; Petersen E; de Witte T; Kröger N;
    Leukemia; 2013 Apr; 27(4):879-88. PubMed ID: 23164802
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytogenetic abnormalities and monosomal karyotypes in children and adolescents with acute myeloid leukemia: correlations with clinical characteristics and outcome.
    Manola KN; Panitsas F; Polychronopoulou S; Daraki A; Karakosta M; Stavropoulou C; Avgerinou G; Hatzipantelis E; Pantelias G; Sambani C; Pagoni M
    Cancer Genet; 2013 Mar; 206(3):63-72. PubMed ID: 23411131
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Late intensification chemotherapy has not improved the results of intensive chemotherapy in adult acute lymphoblastic leukemia. Results of a prospective multicenter randomized trial (PETHEMA ALL-89). Spanish Society of Hematology.
    Ribera JM; Ortega JJ; Oriol A; Fontanillas M; Hernández-Rivas JM; Brunet S; García-Conde J; Maldonado J; Zuazu J; Gardella S; Besalduch J; León P; Macià J; Domingo-Albós A; Feliu E; San Miguel JF
    Haematologica; 1998 Mar; 83(3):222-30. PubMed ID: 9573676
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Different prognosis of acute myeloid leukemia harboring monosomal karyotype with total or partial monosomies determined by FISH: retrospective PALG study.
    Wawrzyniak E; Wierzbowska A; Kotkowska A; Siemieniuk-Rys M; Robak T; Knopinska-Posluszny W; Klonowska A; Iliszko M; Woroniecka R; Pienkowska-Grela B; Ejduk A; Wach M; Duszenko E; Jaskowiec A; Jakobczyk M; Mucha B; Kosny J; Pluta A; Grosicki S; Holowiecki J; Haus O
    Leuk Res; 2013 Mar; 37(3):293-9. PubMed ID: 23254155
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Efficacies of hematopoietic stem cell transplantation plus imatinib in the treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia: a comparative study].
    Chen J; Wu DP; Chen F; Zhao Y; Sun AN; Qiu HY
    Zhonghua Yi Xue Za Zhi; 2013 Feb; 93(8):583-7. PubMed ID: 23663336
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Monosomal karyotype in acute myeloid leukemia predicts adverse treatment outcome and associates with high functional multidrug resistance activity.
    Ahn HK; Jang JH; Kim K; Kim HJ; Kim SH; Jung CW; Kim DH
    Am J Hematol; 2012 Jan; 87(1):37-41. PubMed ID: 22120708
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IPSS-R in 555 Taiwanese patients with primary MDS: Integration of monosomal karyotype can better risk-stratify the patients.
    Yang YT; Hou HA; Liu CY; Lin CC; Chou WC; Lee FY; Liu MC; Liu CW; Tang JL; Yao M; Li CC; Kuo YY; Huang SY; Ko BS; Chen CY; Hsu SC; Lin CT; Wu SJ; Tsay W; Chen YC; Tien HF
    Am J Hematol; 2014 Sep; 89(9):E142-9. PubMed ID: 24845799
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical characteristics and outcomes of 59 patients with acute lymphoblastic leukemia positive for BCR/ABL].
    Liu Z; Liu XL; Du QF; Xu N; Zhong M; Song LL; Yi ZS; Liu QF; Meng FY; Zhou SY
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 Mar; 29(3):512-5. PubMed ID: 19304540
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognosis of acute myeloid leukemia harboring monosomal karyotype in patients treated with or without allogeneic hematopoietic cell transplantation after achieving complete remission.
    Yanada M; Kurosawa S; Yamaguchi T; Yamashita T; Moriuchi Y; Ago H; Takeuchi J; Nakamae H; Taguchi J; Sakura T; Takamatsu Y; Waki F; Yokoyama H; Watanabe M; Emi N; Fukuda T
    Haematologica; 2012 Jun; 97(6):915-8. PubMed ID: 22180431
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Randomized comparison of prophylactic and minimal residual disease-triggered imatinib after allogeneic stem cell transplantation for BCR-ABL1-positive acute lymphoblastic leukemia.
    Pfeifer H; Wassmann B; Bethge W; Dengler J; Bornhäuser M; Stadler M; Beelen D; Vucinic V; Burmeister T; Stelljes M; Faul C; Dreger P; Kiani A; Schäfer-Eckart K; Schwerdtfeger R; Lange E; Kubuschok B; Horst HA; Gramatzki M; Brück P; Serve H; Hoelzer D; Gökbuget N; Ottmann OG;
    Leukemia; 2013 Jun; 27(6):1254-62. PubMed ID: 23212150
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monosomal karyotype in MDS: explaining the poor prognosis?
    Schanz J; Tüchler H; Solé F; Mallo M; Luño E; Cervera J; Grau J; Hildebrandt B; Slovak ML; Ohyashiki K; Steidl C; Fonatsch C; Pfeilstöcker M; Nösslinger T; Valent P; Giagounidis A; Aul C; Lübbert M; Stauder R; Krieger O; Le Beau MM; Bennett JM; Greenberg P; Germing U; Haase D
    Leukemia; 2013 Oct; 27(10):1988-95. PubMed ID: 23787396
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic implications of chromosome 17 abnormalities in the context of monosomal karyotype in patients with acute myeloid leukemia and complex cytogenetics.
    Nazha A; Kantarjian HM; Bhatt VR; Nogueras-Gonzalez G; Cortes JE; Kadia T; Garcia-Manero G; Abruzzo L; Daver N; Pemmaraju N; Quintas-Cardama A; Ravandi F; Keating M; Borthakur G
    Clin Lymphoma Myeloma Leuk; 2014 Apr; 14(2):163-71. PubMed ID: 24461514
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Monosomal karyotype in adult acute myeloid leukemia: prognostic impact and outcome after different treatment strategies.
    Kayser S; Zucknick M; Döhner K; Krauter J; Köhne CH; Horst HA; Held G; von Lilienfeld-Toal M; Wilhelm S; Rummel M; Germing U; Götze K; Nachbaur D; Schlegelberger B; Göhring G; Späth D; Morlok C; Teleanu V; Ganser A; Döhner H; Schlenk RF;
    Blood; 2012 Jan; 119(2):551-8. PubMed ID: 22096250
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcome of allogeneic stem cell transplantation in myelodysplastic syndrome patients: prognostic implication of monosomal karyotype.
    Wudhikarn K; Van Rheeden R; Leopold C; Rattanaumpawan P; Gingrich R; de Magalhaes Silverman M
    Eur J Haematol; 2012 Oct; 89(4):294-301. PubMed ID: 22762733
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute leukemia treated with intensive chemotherapy in patients with a history of previous chemo- and/or radiotherapy: prognostic significance of karyotype and preceding myelodysplastic syndrome. Groupe Francais de Cytogénétique Hématologique (GFCH).
    Leukemia; 1994 Jan; 8(1):87-91. PubMed ID: 8289504
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Frequency and prognostic significance of additional cytogenetic abnormalities to the Philadelphia chromosome in young and older adults with acute lymphoblastic leukemia.
    Motlló C; Ribera JM; Morgades M; Granada I; Montesinos P; Mercadal S; González-Campos J; Moreno MJ; Barba P; Cervera M; Barrios M; Novo A; Bernal T; Hernández-Rivas JM; Abella E; Amigo ML; Tormo M; Martino R; Lavilla E; Bergua J; Serrano A; García-Belmonte D; Guàrdia R; Grau J; Feliu E;
    Leuk Lymphoma; 2018 Jan; 59(1):146-154. PubMed ID: 28554259
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.